Cargando...
Chimeric Antigen Receptor T-Cells: The Future Is Now
The immune system acting via cancer immune-surveillance is considered a potential target for improving outcomes among some malignancies. The ability to harness immune cells, engineer them and educate them to target cancer cells has changed the paradigm for treating non-Hodgkin’s lymphomas (NHL) and...
Gardado en:
| Publicado en: | J Clin Med |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
MDPI
2019
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6406995/ https://ncbi.nlm.nih.gov/pubmed/30736426 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm8020207 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|